Clinical trial
Safety, Efficacy and Impact on Quality of Life of Long-Term Administration of Dilaudid CR (Hydromorphone HCI) in Patients With Chronic Low Back Pain
NCT00411268 is registered in ClinicalTrials.gov with Alza Corporation, DE, USA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety, Efficacy and Impact on Quality of Life of Long-Term Administration of Dilaudid CR (Hydromorphone HCI) in Patients With Chronic Low Back Pain
- Lead sponsor
- Alza Corporation, DE, USA
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- June 30, 2001
- Enrollment
- 207 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.